PE20242069A1 - Sintesis de inhibidores de tirosina quinasa de bruton - Google Patents
Sintesis de inhibidores de tirosina quinasa de brutonInfo
- Publication number
- PE20242069A1 PE20242069A1 PE2024001734A PE2024001734A PE20242069A1 PE 20242069 A1 PE20242069 A1 PE 20242069A1 PE 2024001734 A PE2024001734 A PE 2024001734A PE 2024001734 A PE2024001734 A PE 2024001734A PE 20242069 A1 PE20242069 A1 PE 20242069A1
- Authority
- PE
- Peru
- Prior art keywords
- tyrosine kinase
- kinase inhibitors
- synthesis
- bruton tyrosine
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Health & Medical Sciences (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Pyridine Compounds (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20220100151 | 2022-02-18 | ||
| EP22167032 | 2022-04-06 | ||
| EP22178413 | 2022-06-10 | ||
| PCT/EP2023/054043 WO2023156599A1 (en) | 2022-02-18 | 2023-02-17 | Synthesis of bruton's tyrosine kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20242069A1 true PE20242069A1 (es) | 2024-10-18 |
Family
ID=85227338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2024001734A PE20242069A1 (es) | 2022-02-18 | 2023-02-17 | Sintesis de inhibidores de tirosina quinasa de bruton |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20250163076A1 (https=) |
| EP (1) | EP4479405A1 (https=) |
| JP (1) | JP2025506671A (https=) |
| KR (1) | KR20240148351A (https=) |
| AU (1) | AU2023221549A1 (https=) |
| CA (1) | CA3252338A1 (https=) |
| CL (1) | CL2024002409A1 (https=) |
| CO (1) | CO2024011229A2 (https=) |
| IL (1) | IL314902A (https=) |
| JO (1) | JOP20240182A1 (https=) |
| MX (1) | MX2024010134A (https=) |
| PE (1) | PE20242069A1 (https=) |
| WO (1) | WO2023156599A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025262118A1 (en) * | 2024-06-20 | 2025-12-26 | Janssen Pharmaceutica Nv | Combination therapy using a malt1 inhibitor and a btk inhibitor |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3794B1 (ar) * | 2015-12-10 | 2021-01-31 | Janssen Pharmaceutica Nv | المركبات متعددة الحلقات كمثبطات لتيروزين كيناز بروتون |
| WO2018103060A1 (en) * | 2016-12-09 | 2018-06-14 | Janssen Pharmaceutica Nv | Inhibitors of bruton's tyrosine kinase and methods of their use |
-
2023
- 2023-02-17 AU AU2023221549A patent/AU2023221549A1/en active Pending
- 2023-02-17 KR KR1020247027226A patent/KR20240148351A/ko active Pending
- 2023-02-17 EP EP23705025.7A patent/EP4479405A1/en active Pending
- 2023-02-17 WO PCT/EP2023/054043 patent/WO2023156599A1/en not_active Ceased
- 2023-02-17 MX MX2024010134A patent/MX2024010134A/es unknown
- 2023-02-17 JP JP2024547937A patent/JP2025506671A/ja active Pending
- 2023-02-17 IL IL314902A patent/IL314902A/en unknown
- 2023-02-17 PE PE2024001734A patent/PE20242069A1/es unknown
- 2023-02-17 US US18/838,678 patent/US20250163076A1/en active Pending
- 2023-02-17 CA CA3252338A patent/CA3252338A1/en active Pending
-
2024
- 2024-08-12 CL CL2024002409A patent/CL2024002409A1/es unknown
- 2024-08-14 JO JOJO/P/2024/0182A patent/JOP20240182A1/ar unknown
- 2024-08-20 CO CONC2024/0011229A patent/CO2024011229A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2024010134A (es) | 2024-08-27 |
| CA3252338A1 (en) | 2023-08-24 |
| KR20240148351A (ko) | 2024-10-11 |
| EP4479405A1 (en) | 2024-12-25 |
| IL314902A (en) | 2024-10-01 |
| JP2025506671A (ja) | 2025-03-13 |
| JOP20240182A1 (ar) | 2024-08-14 |
| CO2024011229A2 (es) | 2024-08-30 |
| US20250163076A1 (en) | 2025-05-22 |
| WO2023156599A1 (en) | 2023-08-24 |
| AU2023221549A1 (en) | 2024-10-03 |
| CL2024002409A1 (es) | 2025-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2022001091A1 (es) | Dihidrobenzofurano e inden analogos como inhibidores de sarcómero cardíaco (divisional de solicitud 202001871). | |
| PE20252338A1 (es) | Compuesto agonista de receptor thrb y metodo de preparacion | |
| PE20220134A1 (es) | Compuestos de pirrolidina | |
| PE20230560A1 (es) | Inhibidores de rip1k | |
| NO20060145L (no) | Substituerte indazolyl (indolyl) maleimidderivater som kinase inhibitorer | |
| AR090488A1 (es) | Derivados de n-ciclobutilbenzamida, un proceso para su obtencion, intermediarios para su sintesis, composiciones pesticidas y farmaceuticas que los comprenden y metodos para controlar daños debidos a una plaga y/u hongos | |
| AR054560A1 (es) | Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer | |
| CR20230529A (es) | Inhibidores de nlrp3 | |
| EA200701640A1 (ru) | Новые соединения с терапевтическим эффектом | |
| PE20190329A1 (es) | Compuestos moduladores de fxr (nr1h4) | |
| EA200401378A1 (ru) | N-замещенные трициклические 3-аминопиразолы в качестве ингибиторов pdgf рецептора | |
| CY1114213T1 (el) | Μεθοδοι απομονωσης κρυσταλλικης μορφης ι της 5-αζακυτιδινης | |
| AR040773A1 (es) | Pirazoles utiles como inhibidores de gsk-3 | |
| WO2009109991A3 (en) | Novel hydrazide containing tyrosine kinase inhibitors | |
| PE20060583A1 (es) | Tiazolil-dihidro-indazoles como inhibidores de pi3-quinasas | |
| AR035777A1 (es) | Derivados de pirazol sustituidos, procesos para su preparacion, composiciones farmaceuticas que los contienen, y su uso en medicina | |
| EA029278B1 (ru) | Новые 4,6-дизамещенные аминопиримидиновые производные | |
| AR116906A1 (es) | Derivados de heteroarilo bicíclico | |
| PE20232047A1 (es) | Quinolinas y azaquinolinas como inhibidores de cd38 | |
| PE20211447A1 (es) | Indazol-3-carboxamidas sustituidas con 5-heteroarilo y preparacion y uso de las mismas | |
| PE20242069A1 (es) | Sintesis de inhibidores de tirosina quinasa de bruton | |
| MX2025005972A (es) | Compuestos novedosos como moduladores de la inhibicion de la proteina 3 que contiene un dominio de pirina de la familia de receptores similares al dominio de oligomerizacion de union a nucleotidos (nlrp3) | |
| AR119198A1 (es) | Proceso para la preparación de inhibidores del canal de cloruro cic-1 | |
| MX2025001765A (es) | Derivados deuterados de pirimidin-2-il sulfonamida | |
| Soeta et al. | [4+ 1] Cycloaddition of N-acylimine derivatives with isocyanides: efficient synthesis of 5-aminooxazoles and 5-aminothiazoles |